Please check your internet connection and try again.
# Acetylcysteine
## Overview
Acetylcysteine is a mucolytic agent that helps break down mucus in the airways, making it easier to cough up. It also acts as an antidote for acetaminophen overdose by replenishing glutathione stores.
## Primary Indications
* **Mucolytic:** To thin and loosen mucus in patients with chronic bronchitis, emphysema, cystic fibrosis, and other respiratory conditions characterized by excessive or viscous mucus.
* **Acetaminophen Overdose Antidote:** To prevent or reduce liver damage following an acetaminophen overdose.
## Adult Dosing
### Mucolytic
* **Oral/Nebulized:** Typically 200 mg to 600 mg two to four times daily. Specific dosing depends on the condition and formulation. Some protocols may recommend doses up to 1200 mg per day.
* **Intravenous (IV) Preparation:** Not FDA-approved for mucolytic use via IV.
### Acetaminophen Overdose Antidote
* **Oral:** A loading dose of 140 mg/kg is given, followed by 70 mg/kg every 4 hours for 17 doses (total 72 hours).
* **Intravenous (IV):** Follow specific hospital protocols. A common regimen involves an initial dose, followed by a second dose 4 hours later, and then subsequent doses every 4 to 16 hours depending on the protocol. Dosing is weight-based and can involve high initial doses.
## Pediatric Dosing
### Mucolytic
* **Oral:** 50 mg/kg twice daily, up to a maximum of 800 mg/day.
* **Nebulized:** 10% solution: 1-3 mL every 2-6 hours. 20% solution: 1-2 mL every 2-6 hours. Dosing may be adjusted based on patient response and tolerance.
### Acetaminophen Overdose Antidote
* **Oral:** Same as adult dosing: 140 mg/kg loading dose, then 70 mg/kg every 4 hours for 17 doses.
* **Intravenous (IV):** Follow specific hospital protocols. Dosing is weight-based and can involve high initial doses.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment when used as a mucolytic. For acetaminophen overdose, especially with IV administration, hepatic function should be closely monitored.
## Contraindications
* Hypersensitivity to acetylcysteine or any component of the formulation.
* Active hemorrhage (for IV administration in some protocols).
## Adverse Effects
* **Nebulized:** Bronchospasm, nausea, vomiting, stomatitis, rhinorrhea.
* **Oral:** Nausea, vomiting, diarrhea, rash.
* **Intravenous:** Anaphylactoid reactions (rash, pruritus, urticaria, angioedema, bronchospasm, dyspnea), hypotension, tachycardia.
## Key Drug Interactions
* **Activated Charcoal:** Can bind to oral acetylcysteine, reducing its absorption. If both are administered, separate by at least 1 hour.
* **Nitroglycerin:** May potentiate the vasodilatory effects of nitroglycerin.
## Monitoring
* **Mucolytic Use:** Monitor for improved airway clearance, reduced mucus viscosity, and adverse effects like bronchospasm.
* **Acetaminophen Overdose:** Monitor acetaminophen levels, liver function tests (AST, ALT, bilirubin, INR), and prothrombin time. Close monitoring for anaphylactoid reactions during IV administration is crucial.
## Clinical Pearls
* When nebulizing, pre-treatment with a bronchodilator may be necessary for patients with asthma or reactive airway disease to prevent bronchospasm.
* The characteristic sulfurous odor of acetylcysteine is normal and should not deter administration.
* For IV acetaminophen overdose, prompt administration is critical for efficacy. Delay can lead to irreversible liver damage.
* Always confirm the correct dose and administration route based on the indication (mucolytic vs. overdose antidote) and specific patient factors.
***
**Disclaimer:** This information is intended for clinical use and does not replace professional judgment. Always consult the most current prescribing information and institutional protocols before administering any medication.
